Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancersChris Bryant, Andrew J. Massey|BMC Cancer|2014Cited by 110
Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cellsChris Bryant, Andrew J. Massey|Molecular Cancer|2014Cited by 53